Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 2Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1

Interventions

Cytarabine 23Busulfan 12Peripheral Blood Stem Cell Transplantation 11Cyclophosphamide 10fludarabine phosphate 9Filgrastim 9Cyclosporine 9Antilymphocyte Serum 9Idarubicin 8Methotrexate 7sargramostim 6Mitoxantrone 6Gemtuzumab 6Etoposide 6Daunorubicin 6Radiotherapy 5tipifarnib 4Whole-Body Irradiation 4alvocidib 3Vorinostat 3Tacrolimus 3Mycophenolic Acid 3Methylprednisolone 3Flow Cytometry 3Cytogenetic Analysis 3Cyclosporins 3Clofarabine 3Azacitidine 3merphos 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Megakaryoblastic, Acute × valspodar × Clear all
NCT00004217 2015-03-06

S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

SWOG Cancer Research Network

Phase 2 Completed
55 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡